- Home
- JANX vs STBA Comparison
JANX vs STBA Comparison
Compare JANX & STBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JANX
- STBA
- Stock Information
- Founded
- JANX 2017
- STBA 1902
- Country
- JANX United States
- STBA United States
- Employees
- JANX N/A
- STBA N/A
- Industry
- JANX Biotechnology: Pharmaceutical Preparations
- STBA Major Banks
- Sector
- JANX Health Care
- STBA Finance
- Exchange
- JANX Nasdaq
- STBA Nasdaq
- Market Cap
- JANX 1.4B
- STBA 1.5B
- IPO Year
- JANX 2021
- STBA N/A
- Fundamental
- Price
- JANX $23.98
- STBA $39.58
- Analyst Decision
- JANX Strong Buy
- STBA Hold
- Analyst Count
- JANX 9
- STBA 3
- Target Price
- JANX $85.00
- STBA $42.00
- AVG Volume (30 Days)
- JANX 745.4K
- STBA 127.0K
- Earning Date
- JANX 08-07-2025
- STBA 10-16-2025
- Dividend Yield
- JANX N/A
- STBA 3.44%
- EPS Growth
- JANX N/A
- STBA N/A
- EPS
- JANX N/A
- STBA 3.40
- Revenue
- JANX $439,000.00
- STBA $388,489,000.00
- Revenue This Year
- JANX N/A
- STBA $7.12
- Revenue Next Year
- JANX $591.60
- STBA $5.09
- P/E Ratio
- JANX N/A
- STBA $11.63
- Revenue Growth
- JANX N/A
- STBA 1.05
- 52 Week Low
- JANX $21.97
- STBA $30.84
- 52 Week High
- JANX $71.71
- STBA $45.46
- Technical
- Relative Strength Index (RSI)
- JANX 49.92
- STBA 59.88
- Support Level
- JANX $22.41
- STBA $38.60
- Resistance Level
- JANX $24.00
- STBA $40.08
- Average True Range (ATR)
- JANX 1.10
- STBA 0.86
- MACD
- JANX 0.01
- STBA 0.15
- Stochastic Oscillator
- JANX 42.20
- STBA 74.56
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
About STBA S&T Bancorp Inc.
S&T Bancorp Inc is a bank holding company. The company operates in five markets including Western Pennsylvania, Eastern Pennsylvania, Northeast Ohio, Central Ohio and Upstate New York. The company provides financial services with retail and commercial banking products, cash management services, trust and brokerage services. It operates only in one segment which is Community Banking. The company earns revenue from interest on loans and securities and fees charged for financial services provided to its customers.